RxDoctor Payments Data

Scott Vantre, DPM

Podiatrist · Richmond, VANPI 1003926031

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,009 of the $3,310 with a category attached, or 60.7%. 16 manufacturers reported payments, led by Fortis Surgical, LLC at 44.7% of the total. Reporting peaked in 2020 at $1,540 and has fallen 76.9% since, to $355 in 2025.

$3,310in general payments, 2019–2025

Across 42 payments — averaging $78.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fortis Surgical, LLC$1K
  • Smith+Nephew$554
  • Access Pro Medical, LLC$255
  • Osiris Therapeutics Inc.$247
  • Misonix Inc$132
  • Stryker$123
  • plus $518 from 10 others

What the payments were for

  • Food & beverage$2,00961%
  • Education$1,30139%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,310 in reported general payments places this provider in the 75th percentile of 126 podiatrist providers in Virginia.

See all podiatrist providers in Virginia

Medicare billing

Part B allowed, 2024
$206,204
Medicare patients
777
Services billed
2,785

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin86$1,183
Ciclopirox20$569
Pregabalin12$492
Ketoconazole15$355
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav31$287
Allopurinol14$251
Cephalexin40$204
Ondansetron Hcl25$159
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen19$158
Tramadol Hcl33$106
Ibuprofen24$92
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$53
Meloxicam16$42

Paid to pharmacies, not to this prescriber.

Other podiatrist in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →